The global near-infrared Imaging market is anticipated to grow at a noticeable rate during the forecast period. An increasing number of surgical procedures across the globe for cancer surgery, cardiovascular surgery, plastic surgery and gastrointestinal surgery coupled with the prevalence of target diseases such as lung cancer, prostate cancer, breast cancer, and colon cancer are fueling the growth for near-infrared imaging industry. Cancer surgery is increasing during the forecast period due to the increase in the prevalence of cancer across the globe and the growing use of innovative techniques in cancer detection and therapy has surged the demand for near-infrared imaging technologies.
To Request a Sample of our Report on Global Near Infrared Imaging Market : https://www.omrglobal.com/request-sample/near-infrared-imaging-market-size
Increasing prevalence of chronic diseases and neurological disorder are the factors that significantly drive the near-infrared imaging market. Increase in awareness related to early diagnosis and treatment of cancer supplement the market growth. NIR? II fluorescence imaging overcomes the penetration and contrast bottleneck of imaging in the visible region, making it a remarkable modality for early diagnosis of cancer and highly sensitive tumour surgery. Due to their convenient bio conjugation with peptides and antibodies, NIR? II molecular dyes are desirable candidates for targeted cancer imaging, significantly overcoming the auto fluorescence and scattering issues for deep-tissue molecular imaging.
Recent Merger and Acquisitions in the Near-Infrared Imaging Market
- In 2018, Medtronic acquired vision science, engaged in the development of imaging and visualization solutions for minimally invasive surgeries.
- In 2017, Bracco imaging acquired SurgVision and entered into near-infrared imaging market. SurgVision is a Startup Company that develops Fluorescence image surgery platform solution by using a high definition camera. It has expanded Bracco’s portfolio of imaging solution for healthcare professionals in oncology.
- In 2017, Stryker acquired NOVADAQ Technology, one of the leaders in developing fluorescence imaging technology that offers surgeons with the visualization of blood flow in vessels and related tissue in cardiovascular, gastrointestinal, cardiac, plastic and microsurgical.
Current Market Trends Covered in the Report
- Based on diseases, cancer surgery will hold the highest market share in terms of revenue.
- Based on the region, North America is estimated to maintain the highest revenue contributor during the forecast period.
- Asia-Pacific is the fastest-growing region during the forecast period.
- Based on technology, fluorescence imaging acquired the major share in the near-infrared imaging market.
Near-Infrared Imaging Market Segmentation
By Technology
- Fluorescence Imaging
- Bioluminescence Imaging
By Application
- Cancer Surgery
- Cardiovascular surgery
- Plastic Surgery
- Gastrointestinal Surgery
- Others
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
